Equilibrium adsorption of LDL and gold immunoconjugates to affinity membranes containing PEG spacers
Source abstract
Abstract
The objective of this study was to provide insight into the effects of spacer chemistry on immunoaffinity separations for the capture of large macromolecules and biological complexes. Immunoaffinity membranes were prepared by immobilization of immunoglobulin G (IgG) to flat sheet microporous membranes. Two different systems were examined: immobilized IgG for the immunoadsorption of human low-density lipoprotein (LDL) and immobilized IgG for the immunoadsorption of gold particle immunoconjugate. The IgG was immobilized either directly to the membrane or via a polyethylene glycol (PEG) spacer. Adsorption of LDL was significantly greater for anti-LDL IgG immobilized via PEG than for IgG immobilized directly to the membrane. With the PEG spacer, the adsorption capacity for LDL matched the theoretical density of a monolayer of LDL particles on the membrane surface. The gold particle immunoconjugate, similar in size to LDL, was examined as a generalized model of restrictions to immunoaffinity adsorption of large (>20 nm) biological complexes. Adsorption of gold particles was greater for IgG immobilized via PEG than for IgG immobilized directly to the membrane. It is postulated that the PEG spacer allows lateral movement of the immobilized IgG and dense monolayer packing of adsorbed particles on the membrane surface. These results are pertinent to the removal of LDL from human plasma and the purification of gene therapy delivery vectors, viral vaccines, and other large biological complexes.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Monoclonal and Polyclonal Antibodies Research · Protein purification and stability · RNA Interference and Gene Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (46)
Show source-provided references
1. Membrane based affinity technology for commercial scale purifications10.1038/nbt0788-779 ↗
2. Protein A immobilized affinity cartridge for immunoglobulin purification10.1111/j.1470-8744.1991.tb00154.x ↗
3. 4-4-20 Anti-fluorescyl IgG Fab′ recognition of membrane bound hapten10.1021/bi00036a020 ↗
4. Immobilization of proteins via PEG chains
5. Polyether–polyurethane surfaces10.1016/0021-9797(80)90402-6 ↗
6. Polyethylene oxide as a biomaterial
7. Total internal reflection intrinsic fluorescence (TIRIF) spectroscopy applied to protein adsorption
8. Biological responses to polyethylene oxide modified polyethylene terephthalate surfaces10.1002/jbm.820250704 ↗
9. Surface properties of copolymers of alkyl methacrylates with methoxy(polyethylene oxide)methacrylates and their application as protein-resistant coatings10.1016/0142-9612(90)90058-X ↗
10. Protein adsorption to poly(ethylene oxide) surfaces10.1002/jbm.820251211 ↗
11. Interaction between blood components and hydrogels with poly(oxyethylene) chain
12. ESCA studies of polyurethanes10.1016/0021-9797(81)90203-4 ↗
13. Creating molecular barriers to acute platelet deposition on damaged arteries with reactive polyethylene glycol10.1002/(SICI)1097-4636(199808)41:2<251::AID-JBM10>3.0.CO;2-O ↗
14. Affinity adsorption devices prepared from microporous poly(amide) hollow fibers and sheet membranes10.1016/S0376-7388(96)00328-6 ↗
15. High-throughput processing of proteins using a porous and tentacle anion-exchange membrane10.1016/0021-9673(94)00911-R ↗
16. Binding of lysozyme onto a cation-exchange microporous membrane containing tentacle-type grafted polymer branches10.1021/bp00025a009 ↗
17. Extracorporeal treatment of hypercholesterolemia
18. Three year treatment of familial heterozygous hypercholesterolemia by extracorporeal low-density lipoprotein immunoadsorption with polyclonal apolipoprotein B antibodies10.1016/0026-0495(93)90065-V ↗
19. LDL-Therasorb immunoadsorption for the treatment of severe hypercholesterolemia refractory to conventional therapy10.1111/j.1744-9987.1998.tb00092.x ↗
20. Treatment of familial hypercholesterolemia by means of specific immunoadsorption10.1002/jca.2920040204 ↗
21. Extracorporeal treatment of familial hypercholesterolemia with monoclonal antibodies to low-density lipoprotein10.1016/S0272-6386(12)80650-0 ↗
22. Adsorptive plasma treatment10.1159/000170111 ↗
23. An advanced affinity membrane for immunodiagnostic tests
24. The catalysis of protein and nucleic acid coupling to an affinity membrane substrate
25. du Moulin A. LDL immunoapheresis technique. In: Gotto A, Mancini M, Richter W, Schwandt, P, editors. Treatment of severe hypercholesterolemia in the prevention of coronary heart disease. Proceedings International Symposium Munich, 1989. Basel: Karger, 1990. p. 170–4.
26. Fasman · 1976
27. Immobilization of glycoconjugates by their oligosaccharides10.1016/0003-2697(90)90377-L ↗
28. Site-directed immobilization of glycoproteins on hydrazide-containing solid supports10.1111/j.1470-8744.1987.tb00492.x ↗
29. Box · 1978
30. Studies of a novel membrane for affinity separations. I. Functionalization and protein coupling10.1016/0021-9673(92)85253-P ↗
31. Genetics of the human apolipoproteins
32. Relationship between the size and phospholipid content of low-density lipoproteins10.1016/0005-2760(93)90294-J ↗
33. Soltys PJ. Immunoaffinity membranes for extracorporeal treatment of hypercholesterolemia. University of Wisconsin—Madison, 1997.
34. A surface charge density model for structure and orientation of polymer-bound proteins10.1016/0021-9797(92)90186-P ↗
35. Surface properties of pluronic-coated polymeric colloids10.1021/la00024a016 ↗
36. Hiemenz PC. Polymer chemistry. New York: Marcel Dekker, 1984. p. 48–53.
37. Weast RC. CRC handbook of chemistry and physics. Boca Raton, FL: CRC Press, 1980. p. F218–21.
38. Young RJ. Introduction to polymers. London: Chapman & Hall Ltd., 1981. p. 89–95.10.1007/978-1-4899-3178-8 ↗
39. Introduction to biotechnical and biomedical applications of poly(ethylene glycol)
40. Stoffel W, Borberg H, Greve V. Application of specific extracorporeal removal of low density lipoprotein in familial hypercholesterolemia. Lancet 1981:1005–7.10.1016/S0140-6736(81)91213-7 ↗
41. Impact of immunoadsorption on complement activation, immunopathology, and hepatic perfusion during xenogeneic pig liver perfusion10.1097/00007890-199803150-00023 ↗
42. Clinical trials of immunoadsorbent in systemic lupus erythematosus therapy10.1111/j.1525-1594.1995.tb02360.x ↗
43. Immune modulation associated with extracorporeal immunoadsorption treatments utilizing protein A/silica columns10.1111/j.1525-1594.1996.tb04568.x ↗
44. Phase III trial of Prosorba® column for severe rheumatoid arthritis
45. Study of parameters involved in specific immunoadsorption of apolipoprotein B10.1177/039139889001301109 ↗
46. In vitro characterization of a membrane-based low-density lipoprotein affinity adsorption device10.1159/000014325 ↗